John Houston, departing Arvinas CEO

Q&A: Re­tir­ing Arv­inas CEO John Hous­ton talks PRO­TACs, in­vestor con­fi­dence and what’s next with Pfiz­er

Arv­inas CEO John Hous­ton is plan­ning to re­tire af­ter more than eight years at the helm, the com­pa­ny an­nounced Wednes­day, as its lead pro­tein de­grad­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.